glet oxygen (O 2 ), and hydroxyl radicals (OH). Low levels of ROS are regularly produced during physiological metabolism. To control the redox state, cells possess antioxidant systems that comprise intracellular antioxidants, such as ascorbic acid, glutathione, ␣-tocopherol, and several ROS scavenging enzymes including catalase, glutathione peroxidase, and superoxide dismutase. Cells undergo oxidative stress when levels of ROS exceed the counter-regulatory antioxidant capacity of the cells, either generated from elevated production and accumulation of ROS or from a diminution in cellular antioxidant defenses (1) . Cellular responses to oxidative stress can be as different as cell death, growth arrest, proliferation, or transformation, which are dependent on the stress stimuli, dose or time of exposure, cell type, and surrounding cell environment encountered (1, 2) . ROS-mediated cell damage is implicated in the pathogenesis of a variety of diseases, including diabetes, cancer, atherosclerosis, and Alzheimer's disease (2) .
Exposure to relatively high doses of ROS, such as H 2 O 2 , induces death in many cell types. Oxidative stress-induced cell death involves either necrosis attributable to toxic oxidative damage to cellular lipids, nucleic acids, and proteins or apoptosis resulting from the activation of cell death signaling cascades (1, 3) . On the other hand, oxidative stress can also trigger the activation of certain signaling pathways that protect against cell death, including mitogen-activated protein kinase (4), PI3-kinase/Akt (5, 6), nuclear factor-B (7), and phospholipase C-␥ (8) . PI3-kinase and Akt activation appear to play an essential role in cell survival by preventing the cell death induced by oxidative stress. However, the mechanism by which oxidative stress activates these signaling pathways is not well elucidated. Recent studies have demonstrated that activation of certain growth factor receptors by ROS and subsequent downstream signaling significantly contribute to cell survival (6, 9, 10) . For example, the receptor for epidermal growth factor (6, 9, 11, 12) , platelet-derived growth factor (13, 14) , or insulin (15) each can be activated by H 2 O 2 stimulation. In some cell types, the activation of extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase and Akt in response to ROS appears to be mediated by the stimulation of epidermal growth factor receptor (6, 16) . The activation of epidermal growth factor receptor thus protects against ROS-mediated cell death induced by oxidative stress (6) or ultraviolet irradiation (17) . Hence, the activation of growth factor receptors and down-stream signaling may serve as another protective mechanism against oxidant-mediated cell damage in addition to oxidative scavenger enzymes.
Endothelial cells are primary targets of oxidative stress. Upon exposure to ROS, endothelial cells display a variety of adverse biological effects including the production of inflammatory mediators (18, 19) , expression of adhesion molecules (20, 21) , and increased cell permeability (22, 23) . Addition of exogenous ROS also induces cell death in endothelial cells. ROS-induced endothelium damage or dysfunction is considered to be a primary pathogenetic mechanism in various cardiovascular diseases (24) . ROS may also play a role in angiogenesis. ROS has been reported to induce the production of various angiogenic factors (25) . Interestingly, recent reports have shown that VEGF stimulation elevates the levels of intracellular ROS in endothelial cells, and that ROS is functional as a second messenger and participates in vascular endothelial growth factor receptor (VEGFR)-2 downstream signaling cascades (26, 27) .
VEGFR-3 (VEGFR-3/FLT4) is an orphan receptor for the VEGFRs VEGFR-1 and VEGFR-2 (28) . VEGF-C and VEGF-D have been identified as the ligands for VEGFR-3 (29, 30) . However, VEGF does not bind to VEGFR-3 (29, 30) . VEGFR-3 is predominantly expressed in the lymphatic endothelium of adult tissues and serves as a marker that identifies lymphatic endothelial cells (31) . VEGFR-3 is perhaps the most important regulator of lymphatic development and lymphangiogenesis (32, 33) . VEGFR-3 signaling mediates both angiogenesis and lymphangiogenesis in tumors and appears to play a significant role in tumor metastasis via the lymphatics (34 -36) . In this report, we present evidence that H 2 O 2 can stimulate the tyrosine phosphorylation of the VEGFR-3 receptor, induce its downstream signaling cascade to activate Akt, and thereby promote endothelial cell survival under redox stress. The VEGFR-3 mutants identified in patients with hereditary lymphoedema lack this signaling function, making the lymphatic endothelium especially prone to oxidative damage.
EXPERIMENTAL PROCEDURES
Reagents and Antibodies-Recombinant rat VEGF-C, which can activate human VEGFR-3, was purchased from Calbiochem (La Jolla, CA). Rabbit polyclonal antibody for human VEGFR-3 (FLT4), rabbit polyclonal antibody for human c-Src, and mouse anti-phosphotyrosine (PY) monoclonal antibody PY99 were obtained from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA). Rabbit anti-human antibody against phospholipase C-␥, Shc, or growth factor receptor binding protein 2 was purchased from BD-Transduction Laboratory (San Diego, CA). Rabbit anti-Akt, anti-phospho-Akt, or anti-phospho-Src family (Tyr-416) antibody was obtained from Cell Signaling Technology (Beverly, MA). Normal rabbit serum and purified normal rabbit IgG were purchased from Santa Cruz Biotechnology, Inc. The recombinant human VEGFR-3 (FLT4)/Fc chimera (VEGFR-3/Ig) containing the extracellular domain of human VEGFR-3 and the Fc portion of human immunoglobulin was purchased from R&D Systems (Minneapolis, MN). 4-Amino-5-(4-chlorophenyl)-7-(t-butyl)pyrazolo [3,4-d] pyrimidine (PP2), a Src family kinase (SFK) inhibitor; GF109203X, a protein kinase C (PKC) inhibitor; and PD98059, a mitogen-activated kinase kinase inhibitor, were obtained from Calbiochem. Rottlerin (3Ј-[(8-cinnamoyl-5,7-dihydroxy-2,2-dimethyl-2H-1-benzopyran-6-yl)methyl]-2Ј,4Ј,6Ј-trihydroxy-5Ј methylacetophenone) was obtained from Calbiochem. H 2 O 2 was purchased from Sigma. Electrophoresis reagents and nitrocellulose membrane were obtained from Bio-Rad Laboratories. Protein A-Sepharose CL-4B and GammaBind plus Sepharose were obtained from Amersham Biosciences. The protease inhibitors leupeptin, aprotinin, and alpha 1 antitrypsin and all other reagents were obtained from Sigma. Calcium and potassium-free phosphate-buffered saline was obtained from Invitrogen. [3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl]tetrazolium bromide (MTT) was purchased from Sigma.
Cells and Cell Culture-HMEC-1, a human dermal microvascular endothelial cell line, was kindly provided by the Centers for Disease Control and Prevention (Atlanta, GA) and grown in Dulbecco's modified Eagle's medium with 10% FCS. Human dermal microvascular endothelial cells were purchased from Clonetics Inc. (Palo Alto, CA) and expanded in EGM-2 medium. Five to eight passages were used in the described experiments. Porcine aortic endothelial cells (PAECs) and culture medium were obtained from Cell Applications, Inc. (San Diego, CA). All cells were cultured at 37°C in a humidified atmosphere of 5% CO 2 or VEGF-C for different time periods as indicated at 37°C. In some treatments, cells were incubated with various inhibitors as indicated in each figure legend. After stimulation, cells were washed with ice-cold phosphate-buffered saline containing 0.1 mM sodium orthovanadate, and cell lysates were prepared in a lysis buffer containing 50 mM Hepes, pH 7.0, 150 mM NaCl, 10% glycerol, 1% Triton X-100, 1 mM phenylmethylsulfonyl fluoride, 1 mM sodium orthovanadate, and 10 g/ml each of aprotinin, leupeptin, and pepstatin. Total cell lysates were clarified by centrifugation at 10,000 ϫ g for 10 min. Protein concentrations were determined by protein assay (Bio-Rad Laboratories).
Immunoprecipitation and Western Blot Analysis-Immunoprecipitation and Western blotting were performed as described previously (37) . Briefly, identical amounts of protein from each sample were incubated with different primary antibodies overnight at 4°C. Immunoprecipitation of the antibody-antigen complexes was performed by incubation for 2 h at 4°C with 75 l of protein A-Sepharose or GammaBind plus Sepharose. After washing with lysis buffer, the bound proteins were solubilized in Laemmli sample buffer by boiling for 5 min. Samples were separated on SDS-PAGE, transferred to nitrocellulose membranes, and probed with primary antibody at 4°C overnight. Immunoreactive bands were visualized using horseradish peroxidase-conjugated secondary antibody and the enhanced chemiluminescent (ECL) system (Amersham Biosciences). Each experiment was repeated at least three times, and the presented blots are representative ones.
DNA Constructs, Site-directed Mutagenesis, and Transfection-The expression construct of the wild-type VEGFR-3 or the mutant form of VEGFR-3, with a Gly to Arg mutation at the 857 site, was generated as described previously (37 Total Cellular Phosphatase Activity Assay-Serum-starved HMEC-1 cells were stimulated with H 2 O 2 . Then, cells were lysed in phosphatase lysis buffer (20 mM HEPES (pH 7.4), 10% glycerol, 0.1% Nonidet P-40, 1 mM EGTA, 30 mM ␤-mercaptoethanol, 1 mM phenylmethylsulfonyl fluoride, and leupeptin, antipain, and pepstatin (2 g/ml each)). The protein phosphatase activity was measured by using para-nitrophenyl phosphate as the substrate with the Phosphatase Assay kit (Upstate Biotechnology) according to the manufacturer's instructions. The amount of para-nitrophenyl phosphate produced in the assay reaction was determined by measuring the absorbance at 405 nm.
Cell Survival Assays-HMEC-1 cells or PAECs were plated in collagen-coated 96-well plates and cultured overnight before treatment with various doses of H 2 O 2 . H 2 O 2 or control medium was directly added into the culture medium and then incubated for 30 min at 37°C. Cells were next washed twice with culture medium and cultured for 24 h. Cell survival was determined by using the MTT assay, which determines mitochondrial activity in living cells. 0.1 mg/ml MTT was incubated with the analyzed cells for 4 h at 37°C. Dark blue formazan crystals that formed in the living cells were dissolved by adding 100 l of Me 2 SO. The optical absorbency was measured at 550 -650 nm. Results represent the means of three experiments, and cell survival is expressed as the percentage of control.
Statistical Analysis-The results are expressed as the means Ϯ S.D. of data obtained from three or more experiments performed in triplicate. Statistical significance was determined using Student's t test. Differences were considered as significant at p of 0.05 or less.
RESULTS

H 2 O 2 Induces the Tyrosine Phosphorylation of VEGFR-3 in HMEC-1 Cells and DMVECs-HMEC-1, an immortalized en-
dothelial cell line, was originally derived from dermal microvascular endothelial cells (DMVECs) (38) . HMEC-1 cells possess many of the properties of normal primary endothelial cells (38, 39) . We found that HMEC-1 expressed robust levels of VEGFR-3. To assess whether H 2 O 2 activated VEGFR-3, we first examined the tyrosine phosphorylation of VEGFR-3 in HMEC-1 cells after stimulation with 1.0 mM H 2 O 2 for various times or, in another experiment, used different doses of H 2 O 2 for a set time of 10 min. The tyrosine phosphorylation of VEGFR-3 was measured by precipitation with an anti-VEGFR-3 antibody, followed by Western blotting with an anti-PY monoclonal antibody (PY99). Western blotting with an anti-VEGFR-3 antibody was used to verify equal protein loading. As shown, H 2 O 2 stimulation increased the tyrosine phosphorylation of VEGFR-3 in both a time-and dose-dependent manner (Fig. 1, A and B) . A significant increase in the tyrosine phosphorylation of VEGFR-3 was detected with H 2 O 2 concentrations as low as 0.05 mM (Fig. 1B, upper panel) . The H 2 O 2 -induced tyrosine phosphorylation of VEGFR-3 was detected as early as 1 min, reached a maximum at 30 min, and declined thereafter but was still detectable after 60 min (Fig. 1A , upper panel). This was in contrast to the VEGF-C-induced tyrosine phosphorylation of VEGFR-3, which peaked at 5 min and declined to basal level 30 min after stimulation (data not shown). To confirm that the H 2 O 2 -induced tyrosine phosphorylation of VEGFR-3 was attributable to ROS, the stimulation with H 2 O 2 was performed in the presence of catalase or N-acetylcysteine, a scavenger of ROS and precursor of glutathione. As shown in Fig. 1C , both catalase (1000 units/ml) and N-acetylcysteine (4 mM) inhibited the H 2 O 2 -induced tyrosine phosphorylation of VEGFR-3. We verified that equal amounts of VEGFR-3 were present in each lane of these blots (Fig. 1, A-D, lower panels) .
To exclude the possibility that VEGFR-3 phosphorylation induced by H 2 O 2 was mediated through autocrine stimulation by its natural ligands, HMEC-1 cells were stimulated with H 2 O 2 (1.0 mM) or VEGF-C (50 ng/ml) in the absence or presence of the recombinant human VEGFR-3/Fc chimera protein (VEGFR-3/Ig). VEGFR-3/Ig has been shown to bind to both VEGF-D and VEGF-C and to block ligand/receptor binding (33, 37) . As shown in Fig. 1D , the tyrosine phosphorylation of VEGFR-3 induced by VEGF-C was blocked by VEGFR-3/Ig, whereas the H 2 O 2 -stimulated phosphorylation of VEGFR-3 was not inhibited in the presence of VEGFR-3/Ig. These results indicated that the H 2 O 2 -induced phosphorylation of VEGFR-3 was not mediated by the release of cognate ligands.
We then investigated the effect of H 2 O 2 on the activation of VEGFR-3 in primary endothelial cells (DMVECs) exposed to various doses of H 2 O 2 or to VEGF-C for 10 min. We observed that H 2 O 2 induced the tyrosine phosphorylation of VEGFR-3 in DMVECs in a dose-dependent manner (Fig. 2) . In addition, VEGFR-3 also was activated when the receptor was transiently expressed in PAECs, 293 cells, or NIH-3T3 cells (data not shown), indicating that the H 2 O 2 -induced phosphorylation was not cell type-dependent.
Activation of VEGFR-3 by H 2 O 2 Involves Activation of PKC and SFK and Inhibition of Phosphatase-Previous reports
have suggested that ROS can activate PKC in different cell types (40, 41) . We thus asked whether the tyrosine phosphorylation of VEGFR-3 induced by H 2 O 2 involved the activation of PKC. Before exposure to H 2 O 2 or VEGF-C stimulation, HMEC-1 cells were pretreated with Go6976, a selective inhibitor for PKC␣ or rottlerin, a selective inhibitor of PKC␦, and the tyrosine phosphorylation of VEGFR-3 was then examined. As shown in Fig. 3A , pretreatment with rottlerin but not Go6976 decreased the level of VEGFR-3 phosphorylation in response to H 2 O 2 stimulation as compared with the Me 2 SO control, whereas neither inhibitor altered the VEGF-C-induced phosphorylation of VEGFR-3. Pretreatment with GF109203X, a broader selective inhibitor for various isoforms of PKC, also inhibited the H 2 O 2 -induced tyrosine phosphorylation of VEGFR-3 (Fig. 3B ). These results suggested that H 2 O 2 -mediated receptor activation involved PKC, and most likely the ␦ isoform but not the ␣ isoform.
H 2 O 2 induces the tyrosine phosphorylation of PKC ␣ and ␦ and activates their kinase activity in a phospholipid-independent manner (40, 41) . Although the mechanism whereby H 2 O 2 activates PKC isoforms is not clear, it has been demonstrated that PKC, at least the ␦ isoform, can be activated by SFKs both in vitro and in vivo (42, 43) . Moreover, SFKs are also activated after stimulation with H 2 O 2 in various types of cells (11, 44, 45) . We thus asked whether SFKs are involved in the H 2 O 2 -induced activation of VEGFR-3, possibly by modulating PKC. We examined the role of Src family tyrosine kinases in H 2 O 2 -induced VEGFR-3 phosphorylation by using PP2, a specific inhibitor for SFKs. As shown in Fig. 4A , the H 2 O 2 -stimulated tyrosine phosphorylation of VEGFR-3 was completely blocked in the presence of 10 M PP2. These results suggested that SFKs are also involved in H 2 O 2 -induced VEGFR-3 activation. We also analyzed the tyrosine phosphorylation of PKC ␣ or ␦ after H 2 O 2 stimulation. We found that the tyrosine phosphorylation of PKC ␣ or ␦ in response to H 2 O 2 stimulation was inhibited by PP2 (Fig. 4, B and C) .
To demonstrate further the involvement of SFKs in the H 2 O 2 -induced phosphorylation of VEGFR-3 and PKC, we transfected HMEC-1 cells with a dominant-negative mutant of Src or the control empty vector. This dominant-negative Src can block the downstream signaling of various SFK members, because it encodes both the K296R and Y528F mutations that can bind to phosphotyrosine docking sites but are unable to phosphorylate downstream targets. As shown, transfection of cells with this dominant-negative construct resulted in a significant reduction in the tyrosine phosphorylation of VEGFR-3 (Fig. 5A) , PKC␣ (Fig. 5B) , and PKC␦ (Fig. 5C ) after H 2 O 2 stimulation. These results indicated that the H 2 O 2 -induced activation of both VEGFR-3 and PKC isoforms required SFK activity.
Previous studies have shown that protein tyrosine phosphatases (PTPs) are direct targets for ROS (46 -48) . ROS inhibit PTP activities by inducing reversible oxidation of the catalytic cysteine residues. In HMEC-1 cells, we observed that treatment with H 2 O 2 inhibited total phosphatase activity in a dose-dependent manner (Fig. 6 ). These data suggested that inhibition of phosphatases is involved in H 2 O 2 -induced VEGFR-3 activation. To determine whether inhibition of PTPs is sufficient to induce the tyrosine phosphorylation of VEGFR-3, we treated serumstarved HMEC-1 cells with sodium orthovanadate (Na 3 VO 4 ), a potent general inhibitor of phosphatases. As shown in Fig. 7A , this treatment enhanced the tyrosine phosphorylation of VEGFR-3. Similar to H 2 O 2 , the sodium orthovanadate-induced phosphorylation of VEGFR-3 was also inhibited by pretreatment with PP2 (Fig. 7A) . Furthermore, both sodium orthovanadate and H 2 O 2 stimulated the phosphorylation of Tyr-416, a kinase activation site of the SFKs (Fig. 7B) . These results indicated that the inhibition of PTPs may, at least in part, account for the observed phosphorylation of VEGFR-3 through activation of SFKs after H 2 O 2 stimulation.
H 2 O 2 Stimulation Induces the Association of VEGFR-3 with Its Downstream Signaling Molecules-
The tyrosine phosphorylation of tyrosine kinase receptors transmits signals by recruiting SH2 domain-containing signaling proteins. To explore whether the H 2 O 2 -induced phosphorylation of VEGFR-3 was functional, we examined the immunocomplexes formed between VEGFR-3 and downstream adaptor proteins. HMEC-1 cells were exposed to H 2 O 2 treatment, and then cell lysates were prepared and immunoprecipitated with anti-VEGFR-3 antibody. The immunoprecipitates were resolved on 8% SDS-PAGE gel and subjected to sequential Western blotting with antibodies against various signaling molecules. As shown in Fig. 8 , the association of VEGFR-3 with the p85 subunit of PI3-kinase (Fig. 8A) , Shc (Fig. 8B), Grb2 (Fig. 8C ), SHP-2 ( Fig.  8D) , or phospholipase C-␥ (Fig. 8E) was enhanced after the treatment with H 2 O 2 . These results suggested that the H 2 O 2 -induced activation of VEGFR-3 was able to initiate downstream signaling by recruiting adaptor molecules. We first used MAZ51, a recently identified selective inhibitor for VEGFR-3 (49) . HMEC-1 cells were pretreated with 5 M MAZ51 or control Me 2 SO for 30 min, followed by stimulation with different doses of H 2 O 2 or VEGF-C (150 ng/ml). The phosphorylation of Akt was examined by Western blotting using specific antibody against phospho-Akt. As shown in Fig. 9 , H 2 O 2 or VEGF-C stimulated the phosphorylation of Akt, whereas treatment with MAZ51 inhibited the Akt phosphorylation induced either by H 2 O 2 or by VEGF-C. These results suggested that VEGFR-3 might be involved in the activation of Akt induced by H 2 O 2 .
Activation of VEGFR-3 by H 2 O 2 Stimulation Contributes to the Activation of Akt and Enhances Cell Survival-ROS
To further investigate the role of VEGFR-3 in H 2 O 2 -induced Akt activation, we examined the phosphorylation of Akt by H 2 O 2 in the presence of vector, wild-type, or a kinase-inactive mutant form of VEGFR-3 using a transfection cell model. We used PAECs, which do not express endogenous VEGFR-3 (50). In addition, PAECs appear to express very low, if any, levels of VEGFR-1 (51), VEGFR-2 (51), EGFR (52), or platelet-derived growth factor receptor (53) . Thus, using PAECs would minimize the possible effects of these growth factor receptors on Akt activation after H 2 O 2 stimulation because receptors such as epidermal growth factor receptor or platelet-derived growth factor receptor are also targets of ROS.
VEGFR-3/G857R is a G-R mutant located in the first kinase domain of VEGFR-3, originally identified in patients with hereditary lymphoedema (54, 55) . This mutation results in the loss of receptor kinase activity and unresponsiveness to ligand stimulation (33, 37, 54, 55). As shown in Fig. 10A , when transiently expressed in PAECs, wild-type VEGFR-3 was tyrosinephosphorylated after H 2 O 2 or VEGF-C stimulation, whereas the mutant form of VEGFR-3 was not phosphorylated by either stimulus. There was no endogenous VEGFR-3 in the control vector-transfected PAECs, as detected by immunoprecipitation and Western blotting using anti-VEGFR-3-specific antibody. These results suggested that receptor kinase activity could be required for the H 2 O 2 -induced phosphorylation of VEGFR-3.
To examine activation of Akt, the wild-type or mutant form of VEGFR-3-transfected or control vector-transfected PAECs were stimulated by either H 2 O 2 or VEGF-C. Cell lysates were analyzed by Western blotting using anti-phospho-Akt antibody. As shown in Fig. 10B , the H 2 O 2 -induced phosphorylation of Akt was significantly increased in the wild-type but not in the mutant VEGFR-3-transfected cells as compared with the control vectortransfected cells. VEGF-C only stimulated Akt phosphorylation in the wild-type VEGFR-3-transfected cells. These data demonstrated that the stimulation of VEGFR-3 contributed to the activation of Akt in response to H 2 O 2 exposure.
Next, we investigated whether VEGFR-3 signaling could protect cells from ROS-induced cell death in addition to activating Akt. Cell survival assays were performed by applying MAZ51 in HMEC-1 cells or by using the VEGFR-3-transfected PAEC model after exposure to various does of H 2 O 2 . As shown, exposure to H 2 O 2 for 30 min induced cell death in both HMEC-1 (Fig. 11A) and PAECs (Fig. 11B ) in a dose-dependent manner. In HMEC-1 cells, applying MAZ51 further decreased cell survival after H 2 O 2 treatment (Fig. 11A) , although there were no significant effects of MAZ51 on survival in cells untreated with H 2 O 2 (data not shown). These results suggested that blocking VEGFR-3 signaling promoted H 2 O 2 -induced cell death. In PAECs, transfection of the wild-type VEGFR-3 enhanced cell survival after H 2 O 2 exposure as compared with cells transfected with either the mutant form of VEGFR-3 or the control expressing vector alone (Fig. 11B) . These data indicated that the presence of VEGFR-3 and its activation contributed to cell survival.
DISCUSSION
Using model HMEC-1 cells, we found that H 2 O 2 treatment induced the tyrosine phosphorylation of VEGFR-3 (Fig. 1) . The activation of VEGFR-3 was not attributable to the induction of VEGFR-3 ligands because it was not blocked by the soluble ectodomain of the receptor. Activation was inhibited by the anti-oxidant reagent, N-acetylcysteine, as well as by catalase. The activation of VEGFR-3 by H 2 O 2 was also confirmed in primary endothelial cells, DMVECs (Fig. 2) . Thus, VEGFR-3, similar to certain other tyrosine kinase receptors including epidermal growth factor receptor (6, 9, 11, 12), platelet-derived growth factor receptor (13, 14) , and the insulin receptor (15) , is a target for ROS.
One important issue addressed in our study is whether H 2 O 2 -mediated activation of VEGFR-3 is functional in transmitting its downstream signaling. We demonstrated that VEGFR-3 could associate with various SH2-containing molecules, which are believed to mediate the signaling of tyrosine kinase receptors to downstream substrates (Fig. 8) , indicating that H 2 O 2 -mediated activation of VEGFR-3 was functional. Furthermore, we showed that VEGFR-3 signaling contributed to the activation of Akt (Figs. 9 and 10) , a critical pathway in cell survival. The role of Akt in protecting against ROS-induced cell death has been extensively documented (1, 5, 6) . Our results clearly demonstrated the involvement of VEGFR-3 in preventing H 2 O 2 -induced cell death in endothelial cells (Fig.  11) . Thus, similar to other growth factor receptors, VEGFR-3 can serve as a cell survival modulator under oxidative stress.
Considering the critical roles of VEGFR-3 in the develop- ment of the lymphatic system and its biological action in maintaining the structural and functional integrity of lymphatic endothelium and lymphangiogenesis (29 -33) , the findings in this report may have some practical implications in understanding lymphatic-related diseases. For example, chronic lymphoedema is a disease involving lymphatic dysfunction, either developed as a congenital disorder or generated secondary to other diseases such as cancer or filarial parasites. Enhanced formation of ROS and accelerated lipid peroxidation processes have been detected in lymphoedematous tissue, which are considered to contribute to the damage of lymphatic endothelium (56, 57) . The expression of VEGFR-3 in lymphatics, along with cellular anti-oxidative defense molecules, likely plays a role in protecting against ROS-induced cell damage. The functional loss of VEGFR-3 may facilitate disease-related pathological processes. Indeed, we found that the mutant form of VEGFR-3 (VEGFR-3/G857R) did not respond to the stimulation by H 2 O 2 and failed both to activate Akt (Fig. 10 ) and to prevent cell death under oxidative stress (Fig. 11) . This mutant and other mutations in the intracellular kinase domains of VEGFR-3 have been identified among families with hereditary lymphoedema (54, 55) . These mutations result in the loss of receptor kinase activity and have been proposed as the cause of the disease. Thus, approaches to restore receptor function directly or indirectly through alternative receptor signaling could be beneficial in treating this disease (58, 59) .
It is well known that tumors generate significantly higher levels of ROS than normal tissues (60) . ROS likely contribute to the increased angiogenesis observed in malignancy by inducing the production of angiogenic factors such as VEGF, IL-8, and the expression of metalloproteinases (61) . More recent evidence implicates VEGFR-3-mediated lymphangiogenesis in tumor metastasis (34 -36) . The level of H 2 O 2 in some tumors could reach levels beyond those required to activate VEGFR-3 ( Fig.  1) . On the basis of the observations in this study, it is possible that ROS may also contribute to lymphangiogenesis through activation of VEGFR-3 in tumor tissue.
Although the precise mechanism whereby ROS activate receptor tyrosine kinases is not clear, a plausible explanation is the inactivation of PTPs (26, 27, 62) . The catalytic sites of PTPs contain reactive cysteine residues and form thiol-phosphate intermediates during catalysis. The thiol oxidation of these residues leads to inactivation of PTPs. H 2 O 2 has been shown to reversibly inactivate PTPs (46) . PTPs are believed to inhibit tyrosine kinase receptors by virtue of dephosphorylation; therefore, inactivation of PTPs would thereby increase receptor phosphorylation (47, 48) . Indeed, we demonstrated that H 2 O 2 could inhibit total protein phosphatase activity in HMEC-1 cells. Treatment of cells with sodium orthovanadate, a potent general inhibitor of phosphatases, also induced the tyrosine phosphorylation of VEGFR-3. These results suggested that inhibition of PTPs was involved in the H 2 O 2 -induced phosphorylation of VEGFR-3, similar to findings from other receptor tyrosine kinases (47, 48) . However, the inactivation of PTPs and the subsequent inhibited dephosphorylation of tyrosine kinase receptors may not be the only mechanism for the increases in receptor tyrosine phosphorylation induced by ROS. Our results demonstrated that the H 2 O 2 -induced phosphorylation of VEGFR-3 could be inhibited either by treatment with the SFK-specific inhibitor, PP2, or by overexpression of a dominant-negative Src construct (with K296R and Y528F mutations), thereby indicating that the activation of VEGFR-3 requires SFKs (Figs. 4 and 5) . Furthermore, we observed a significant increase in Src kinase activity in HMEC-1 cells after H 2 O 2 stimulation (Fig. 7B) . Moreover, the sodium orthovanadate-induced phosphorylation of VEGFR-3 was also inhibited by PP2 (Fig. 7A) . Our studies further showed that, similar to H 2 O 2, sodium orthovanadate activated c-Src kinase (Fig. 7B) . Taken together, our results suggest that the H 2 O 2 -induced phosphorylation of VEGFR-3 requires activation of SFKs and that these effects probably are, at least in part, mediated by the inhibition of PTPs. Previous studies have shown that other tyrosine kinase receptors such as epidermal growth factor receptor also require SFKs for H 2 O 2 -induced activation (11) . These results suggest that SFK-dependent activation may serve as a common mechanism among tyrosine kinase receptors in their response to ROS stimulation. However, it is not clear how SFKs induce the phosphorylation of tyrosine kinase receptors, although it has been observed that some growth factor receptors such as epidermal growth factor receptor (63) and Ron (64) are directly phosphorylated by Src.
Our results indicated that the phosphorylation of VEGFR-3 induced by H 2 O 2 also required PKC in addition to SFKs (Figs.  3 and 4) . H 2 O 2 can activate various isoforms of PKC along with their phosphorylation on tyrosine (40, 41) . Consistent with a previous report (13), we observed that the H 2 O 2 -induced tyrosine phosphorylation of PKC ␣ or ␦ was inhibited by PP2 (Fig.  4, B and C) or by overexpression of a dominant-negative mutant of c-Src (Fig. 5) . Because Src can directly phosphorylate these PKC isoforms on tyrosine and activate their kinase activities both in vivo and in vitro (42, 65) , it is plausible to propose that the contribution of SFKs to the H 2 O 2 -mediated phosphorylation of VEGFR-3 may take place upstream of PKC. While determining which isoform of PKC might modulate the phosphorylation of VEGFR-3 after H 2 O 2 stimulation, we observed that H 2 O 2 -induced phosphorylation of VEGFR-3 was diminished by inhibition of PKC␦ but not ␣. PKC␦ was requisite for H 2 O 2 -induced but not for VEGF-C-induced tyrosine phosphorylation of VEGFR-3 (Fig. 3A ). This further suggested that H 2 O 2 activated this receptor through distinct mechanisms other than through receptor ligands. Thus, our study indicated that the activation of VEGFR-3 in response to H 2 O 2 was probably initiated by intracellular kinases, such as SFKs and PKC␦, rather than by extracellular ligand stimulation.
Because ROS and VEGFR-3 are strongly implicated in lymphatic diseases as well as in normal lymph development and lymphangiogenesis, the potent activation of VEGFR-3 and its functional signaling by ROS may provide new mechanistic insights into both physiological and pathological processes in lymphatic endothelium.
